This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción GNBT
Generex Biotechnology Corporation, through its subsidiaries, engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States.
Resumen de todos los máximos históricos, cambios y caídas de precios de Generex Biotechnology
Precios históricos de las acciones
Precio actual de la acción
US$0.0005
Máximo en las últimas 52 semanas
US$0.32
Mínimo de 52 semanas
US$0.0001
Beta
-1.69
1Cambio en 1 mes
-77.27%
Variación en 3 meses
0%
Cambio de 1 año
-99.79%
3Variación en 3 años
-99.96%
Variación en 5 años
-99.56%
Variación desde la OPV
-100.00%
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
GNBT
US Biotechs
Mercado US
7D
-73.7%
-4.0%
-4.4%
1Y
-99.8%
12.5%
19.1%
Rentabilidad vs. Industria: GNBT underperformed the US Biotechs industry which returned -28.3% over the past year.
Rentabilidad vs. Mercado: GNBT underperformed the US Market which returned -20.6% over the past year.
Volatilidad de los precios
Is GNBT's price volatile compared to industry and market?
GNBT volatility
GNBT Average Weekly Movement
153.3%
Biotechs Industry Average Movement
10.3%
Market Average Movement
6.3%
10% most volatile stocks in US Market
14.9%
10% least volatile stocks in US Market
3.1%
Precio estable de las acciones: GNBT's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: GNBT's weekly volatility has decreased from 242% to 153% over the past year, but is still higher than 75% of US stocks.